Reuters logo
BRIEF-Delmar Pharmaceuticals receives additional non-dilutive funding from government of Canada
January 9, 2017 / 2:29 PM / 8 months ago

BRIEF-Delmar Pharmaceuticals receives additional non-dilutive funding from government of Canada

Jan 9 (Reuters) - Delmar Pharmaceuticals Inc

* Delmar pharmaceuticals receives additional non-dilutive funding from government of canada to support expanded research with lead product candidate val-083 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below